{"id":1156,"date":"2020-08-29T10:03:00","date_gmt":"2020-08-29T04:18:00","guid":{"rendered":"https:\/\/english.kathmandupati.com\/?p=1156"},"modified":"2020-08-29T10:03:28","modified_gmt":"2020-08-29T04:18:28","slug":"1156","status":"publish","type":"post","link":"https:\/\/english.kathmandupati.com\/?p=1156","title":{"rendered":"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials"},"content":{"rendered":"<p class=\"\" style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">BEIJING-Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19.<\/span><\/p>\n<p style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Some of the phase-3 trials are expected to complete the first round of vaccinations in early September, with preliminary data expected as early as November.<\/span><\/p>\n<p style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Phase-3 clinical trials usually involve thousands of people to verify the safety and effectiveness of the vaccines, which are key to their market approval.<\/span><\/p>\n<p style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">As the epidemic has been under control in China, the country no longer has conditions for large-scale clinical trials, so all the phase-3 trials are being carried out overseas.<\/span><\/p>\n<p class=\"\" style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">Two inactivated COVID-19 vaccines developed by the China National Biotec Group (CNBG) have been approved for phase-3 clinical trials in several countries in the Middle East and South America, involving more than 30,000 people, according to Yang Xiaoming, president of the CNBG.<\/span><\/p>\n<p class=\"\" style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">An inactivated COVID-19 vaccine developed by Sinovac Biotech Co., Ltd. is undergoing phase-3 clinical trials in some countries in South America and Southeast Asia, according to Yin Weidong, chairman and CEO of Sinovac.<\/span><\/p>\n<p style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">A recombinant COVID-19 vaccine with the modified defective adenovirus as the vector is also undergoing phase-3 trials.<\/span><\/p>\n<p style=\"font-size: 14pt; font-family: Consolas; text-align: justify;\"><span style=\"font-family: arial, helvetica, sans-serif;\">According to a guideline for the clinical evaluation of COVID-19 vaccines recently released by the National Medical Products Administration, the vaccine should provide immunity for at least six months, preferably for more than a year.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif;\">Xinhua)\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BEIJING-Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19. Some of the phase-3 trials are expected to complete the first round of vaccinations in early September, with preliminary data expected as early as November. Phase-3 clinical trials usually involve thousands of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1157,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[],"class_list":["post-1156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-international"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials - KathmanduPati<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.kathmandupati.com\/?p=1156\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials - KathmanduPati\" \/>\n<meta property=\"og:description\" content=\"BEIJING-Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19. Some of the phase-3 trials are expected to complete the first round of vaccinations in early September, with preliminary data expected as early as November. Phase-3 clinical trials usually involve thousands of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.kathmandupati.com\/?p=1156\" \/>\n<meta property=\"og:site_name\" content=\"KathmanduPati\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/kathmandupatienglish\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-29T04:18:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-29T04:18:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"KathmanduPati\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"KathmanduPati\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156\"},\"author\":{\"name\":\"KathmanduPati\",\"@id\":\"https:\/\/english.kathmandupati.com\/#\/schema\/person\/bbe4e117cde7a3a56af3321608bf6b37\"},\"headline\":\"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials\",\"datePublished\":\"2020-08-29T04:18:00+00:00\",\"dateModified\":\"2020-08-29T04:18:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156\"},\"wordCount\":236,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/english.kathmandupati.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage\"},\"thumbnailUrl\":\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg\",\"articleSection\":[\"International\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/english.kathmandupati.com\/?p=1156#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156\",\"url\":\"https:\/\/english.kathmandupati.com\/?p=1156\",\"name\":\"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials - KathmanduPati\",\"isPartOf\":{\"@id\":\"https:\/\/english.kathmandupati.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage\"},\"image\":{\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage\"},\"thumbnailUrl\":\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg\",\"datePublished\":\"2020-08-29T04:18:00+00:00\",\"dateModified\":\"2020-08-29T04:18:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.kathmandupati.com\/?p=1156\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage\",\"url\":\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg\",\"contentUrl\":\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg\",\"width\":900,\"height\":600,\"caption\":\"File Photo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.kathmandupati.com\/?p=1156#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.kathmandupati.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.kathmandupati.com\/#website\",\"url\":\"https:\/\/english.kathmandupati.com\/\",\"name\":\"KathmanduPati\",\"description\":\"voice of a changing era\",\"publisher\":{\"@id\":\"https:\/\/english.kathmandupati.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.kathmandupati.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.kathmandupati.com\/#organization\",\"name\":\"RB Media House Pvt. Ltd\",\"url\":\"https:\/\/english.kathmandupati.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.kathmandupati.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/cropped-kp-icon.jpg\",\"contentUrl\":\"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/cropped-kp-icon.jpg\",\"width\":512,\"height\":512,\"caption\":\"RB Media House Pvt. Ltd\"},\"image\":{\"@id\":\"https:\/\/english.kathmandupati.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/kathmandupatienglish\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.kathmandupati.com\/#\/schema\/person\/bbe4e117cde7a3a56af3321608bf6b37\",\"name\":\"KathmanduPati\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.kathmandupati.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2699dbc3337f2585abec1155f4432d9c79967e6f836949fbd4e187c84bc3ebc8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2699dbc3337f2585abec1155f4432d9c79967e6f836949fbd4e187c84bc3ebc8?s=96&d=mm&r=g\",\"caption\":\"KathmanduPati\"},\"url\":\"https:\/\/english.kathmandupati.com\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials - KathmanduPati","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.kathmandupati.com\/?p=1156","og_locale":"en_US","og_type":"article","og_title":"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials - KathmanduPati","og_description":"BEIJING-Four Chinese COVID-19 vaccine candidates have started international phase-3 clinical trials, according to the State Council joint prevention and control mechanism against COVID-19. Some of the phase-3 trials are expected to complete the first round of vaccinations in early September, with preliminary data expected as early as November. Phase-3 clinical trials usually involve thousands of [&hellip;]","og_url":"https:\/\/english.kathmandupati.com\/?p=1156","og_site_name":"KathmanduPati","article_publisher":"https:\/\/www.facebook.com\/kathmandupatienglish","article_published_time":"2020-08-29T04:18:00+00:00","article_modified_time":"2020-08-29T04:18:28+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg","type":"image\/jpeg"}],"author":"KathmanduPati","twitter_card":"summary_large_image","twitter_misc":{"Written by":"KathmanduPati","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.kathmandupati.com\/?p=1156#article","isPartOf":{"@id":"https:\/\/english.kathmandupati.com\/?p=1156"},"author":{"name":"KathmanduPati","@id":"https:\/\/english.kathmandupati.com\/#\/schema\/person\/bbe4e117cde7a3a56af3321608bf6b37"},"headline":"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials","datePublished":"2020-08-29T04:18:00+00:00","dateModified":"2020-08-29T04:18:28+00:00","mainEntityOfPage":{"@id":"https:\/\/english.kathmandupati.com\/?p=1156"},"wordCount":236,"commentCount":0,"publisher":{"@id":"https:\/\/english.kathmandupati.com\/#organization"},"image":{"@id":"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage"},"thumbnailUrl":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg","articleSection":["International"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/english.kathmandupati.com\/?p=1156#respond"]}]},{"@type":"WebPage","@id":"https:\/\/english.kathmandupati.com\/?p=1156","url":"https:\/\/english.kathmandupati.com\/?p=1156","name":"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials - KathmanduPati","isPartOf":{"@id":"https:\/\/english.kathmandupati.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage"},"image":{"@id":"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage"},"thumbnailUrl":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg","datePublished":"2020-08-29T04:18:00+00:00","dateModified":"2020-08-29T04:18:28+00:00","breadcrumb":{"@id":"https:\/\/english.kathmandupati.com\/?p=1156#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.kathmandupati.com\/?p=1156"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.kathmandupati.com\/?p=1156#primaryimage","url":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg","contentUrl":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/china-vacine.jpg","width":900,"height":600,"caption":"File Photo"},{"@type":"BreadcrumbList","@id":"https:\/\/english.kathmandupati.com\/?p=1156#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.kathmandupati.com\/"},{"@type":"ListItem","position":2,"name":"Four Chinese COVID-19 vaccines undergoing phase-3 clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/english.kathmandupati.com\/#website","url":"https:\/\/english.kathmandupati.com\/","name":"KathmanduPati","description":"voice of a changing era","publisher":{"@id":"https:\/\/english.kathmandupati.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.kathmandupati.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.kathmandupati.com\/#organization","name":"RB Media House Pvt. Ltd","url":"https:\/\/english.kathmandupati.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.kathmandupati.com\/#\/schema\/logo\/image\/","url":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/cropped-kp-icon.jpg","contentUrl":"https:\/\/english.kathmandupati.com\/wp-content\/uploads\/2020\/08\/cropped-kp-icon.jpg","width":512,"height":512,"caption":"RB Media House Pvt. Ltd"},"image":{"@id":"https:\/\/english.kathmandupati.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/kathmandupatienglish"]},{"@type":"Person","@id":"https:\/\/english.kathmandupati.com\/#\/schema\/person\/bbe4e117cde7a3a56af3321608bf6b37","name":"KathmanduPati","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.kathmandupati.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2699dbc3337f2585abec1155f4432d9c79967e6f836949fbd4e187c84bc3ebc8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2699dbc3337f2585abec1155f4432d9c79967e6f836949fbd4e187c84bc3ebc8?s=96&d=mm&r=g","caption":"KathmanduPati"},"url":"https:\/\/english.kathmandupati.com\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=\/wp\/v2\/posts\/1156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1156"}],"version-history":[{"count":0,"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=\/wp\/v2\/posts\/1156\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=\/wp\/v2\/media\/1157"}],"wp:attachment":[{"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.kathmandupati.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}